NasdaqGM - Nasdaq Real Time Price USD
GH Research PLC (GHRS)
9.53
+0.03
+(0.32%)
As of 12:18:12 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-42,285
-42,285
-33,336
-26,199
-15,283
Investing Cash Flow
65,135
65,135
-54,100
-84,688
-104
Financing Cash Flow
-304
-304
-204
--
286,447
End Cash Position
100,791
100,791
78,420
165,955
276,776
Capital Expenditure
-49
-49
-100
-67
-104
Issuance of Capital Stock
--
--
15
--
309,200
Repayment of Debt
-304
-304
-219
--
--
Free Cash Flow
-42,334
-42,334
-33,436
-26,266
-15,387
12/31/2021 - 6/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATAI Atai Life Sciences N.V.
1.5350
+0.99%
CYBN Cybin Inc.
7.00
+1.16%
CGEM Cullinan Therapeutics, Inc.
8.29
-1.07%
XENE Xenon Pharmaceuticals Inc.
37.59
-0.01%
SCLP.L Scancell Holdings plc
11.25
0.00%
EWTX Edgewise Therapeutics, Inc.
14.91
+0.54%
ATXS Astria Therapeutics, Inc.
5.17
-0.67%
JANX Janux Therapeutics, Inc.
31.75
+0.41%
MRUS Merus N.V.
43.52
+4.04%
VTGN Vistagen Therapeutics, Inc.
2.2550
+3.44%